Study identifies pro-inflammatory macrophage subtype with distinct genetic features in inflamed joints of RA patients.

Stimulating a key metabolic pathway in T cells can make them work more effectively against tumors when combined with immune ...

Prime Medicine will partner with Bristol Myers Squibb (BMS) to develop and commercialize an unspecified number of reagents for ex vivo T-cell therapies through a collaboration that could generate more ...

CEO Katherine Stueland discusses company’s pivot to whole exome sequencing, whole genome sequencing tests for children with GEN Edge.

Researchers say work is underway to genotype the two CD subtypes in order to develop a simple test that can identify which ...

IVF could be improved if a "lost" mechanism to control the pace of human embryonic development could be retored.

Cleveland Clinic researchers have discovered a new bacterium that weakens the immune system in the gut. The findings pave the ...

The developers of the model claim it is the first developed specifically to identify drugs for rare diseases and conditions ...

Getting more effective drugs for patients in need as quickly as possible should be the ultimate reward and objective.

The BPI meeting kicked off on Tuesday morning with an opening plenary session led by Sarah Glaven, from the White House OSTP.

Flagship Pioneering introduced the latest company, Mirai Bio, during the BioProcess International Conference in Boston.

While the cell and gene therapy industry has recognized its potential, few companies to date have embraced artificial ...